Articles
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial
Hori M, Zhu J, Liang Y, et al.
Journal:
Eur Heart J
First published: June 25, 2022 DOI: 10.1093/eurheartj/ehac309